2. UroToday Home
  3. Categories
  4. Conferences
  5. AUA 2014

AUA 2014 - Voiding Dysfunction

#AUA14 - Poster: Retrospective evaluation of efficacy and safety of Argus sling for treatment of male stress urinary incontinence: The Canadian experience

ORLANDO, FL USA (UroToday.com) - Presented by Geneviève Nadeau, Michael Sourial, Michel Bureau, Le-Mai Tu, Greg Bailly, Stephen S. Steele, Kevin Carlson, Richard Baverstock, Neil Dwyer, Luc Valiquette, Jean-Guy Vézina, and Sender Herschorn at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Overactive bladder patients ≥ 65 years of age have a similar efficacy and safety profile with onabotulinumtoxinA as patients less than 65 years of age

ORLANDO, FL USA (UroToday.com) - Presented by Courtenay Moore,1 Albert Kaufmann,2 Manher Joshi,3 Christopher Nardo,3 Yan Zheng,4 and Sender Herschorn5 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Long-term efficacy and safety of repeat onabotulinumtoxinA treatment in overactive bladder syndrome and urinary incontinence: Third interim analysis, median 2.4 years follow-up

ORLANDO, FL USA (UroToday.com) - Presented by Victor Nitti,1 Christopher Chapple,2 David Sussman,3 Sidney Radomski,4 Peter Sand,5 Steven Guard,6 Christopher Nardo,7 Jihao Zhou,8 and Karl-Dietrich Sievert9 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Reduction in urinary incontinence and improvement in quality of life with onabotulinumtoxinA in overactive bladder patients is unaffected by the use of clean intermittent catheterization or the presence of urinary tract infection

ORLANDO, FL USA (UroToday.com) - Presented by David Sussman,1 Jennifer Gruenenfelder,2 Heinrich Schulte-Baukloh,3 Steven Guard,4 Yan Zheng,5 and Karel Everaert6 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Poster: Anticholinergic cycling and treatment outcomes in overactive bladder patients with urinary incontinence

ORLANDO, FL USA (UroToday.com) - Presented by Michael B. Chancellor,1 Riya Pulicharam,2 I-Ning Cheng,2 Karen Campbell,3 Catherine Corbell,3 Manher Joshi,3 and Denise Globe3 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

#AUA14 - Impact of female stress urinary incontinence surgery on pre-op overactive bladder symptoms - Session Highlights

ORLANDO, FL USA (UroToday.com) - The aim of this study was to describe the impact of various stress urinary incontinence (SUI) procedures on pre-operative overactive bladder (OAB) symptoms, up to 5 years after surgery.

#AUA14 - Challenges in the contemporary management of spinal cord injured patients: Panel discussion - Session Highlights

ORLANDO, FL USA (UroToday.com) - Today’s plenary session featured a panel discussion on the “Challenges in the Contemporary Management of Spinal Cord Injured Patients.”  The discussion was moderated by Dr. Michael J. Kennelly and the panelists included Dr. Emmanuel J. Chartier-Kastler, Dr. John Heesakkers, and Dr. David Ginsberg.

#AUA14 - Urinary continence after robotic prostatectomy: Results from a randomized, double-blind multi-center phase 4 clinical trial evaluating solifenacin succinate versus placebo - Session Highlights

ORLANDO, FL USA (UroToday.com) - This presentation provided results from the Vanguard trial, a randomized double-blinded study looking at whether the use of solifenacin succinate after robotic radical prostatectomy resulted in improved urinary continence rates. It is important to note that this study was sponsored by Astellas.